ITM-11 significantly improved PFS and OS in GEP-NET patients compared to everolimus, with a favorable safety profile and higher overall response rates. Dosimetry data showed targeted tumor uptake with ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...

A post hoc analysis of the STARMEN trial found that a combination of three early biomarkers can predict 2-year remission in ...

This important work employed a recent, functional muscle network analysis for evaluating rehabilitation outcomes in post-stroke patients. While the research direction is relevant and suggests the need ...

Explore the 225 quietest hospitals rated five stars by CMS for patient room quietness from Oct 2023 to Sept 2024.

Researchers have found that using mobile-app–based surveys and photography to remotely track and assess atopic dermatitis (AD ...

Background Disappointing outcomes in Sjögren’s disease (SjD) trials underscore the need for reliable, sensitive endpoints.

Do all breast cancer survivors need to see a cardiologist? "It depends!" said Ganz and Yang. Patients who meet criteria ...

Generative artificial intelligence (AI) can transform higher education by enabling guided engagement at scale, fostering ...

DuBois, PA / / October 13, 2025 / Mercy Family Health Key Takeaways Holistic family medicine addresses root causes of health issues rather than just treating symptoms, combining conventional medical ...

The American Heart Association is launching an AI Assessment Lab in partnership with Dandelion Health to validate predictive ...

While Natera said it will seek FDA approval for Signatera based on data from IMvigor011, the readout from another ctDNA-guided de-escalation study was more nuanced.